214 related articles for article (PubMed ID: 26037948)
1. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.
Baik JY; Dahodwala H; Oduah E; Talman L; Gemmill TR; Gasimli L; Datta P; Yang B; Li G; Zhang F; Li L; Linhardt RJ; Campbell AM; Gorfien SF; Sharfstein ST
Biotechnol J; 2015 Jul; 10(7):1067-81. PubMed ID: 26037948
[TBL] [Abstract][Full Text] [Related]
2. Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin.
Baik JY; Gasimli L; Yang B; Datta P; Zhang F; Glass CA; Esko JD; Linhardt RJ; Sharfstein ST
Metab Eng; 2012 Mar; 14(2):81-90. PubMed ID: 22326251
[TBL] [Abstract][Full Text] [Related]
3. Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.
Datta P; Li G; Yang B; Zhao X; Baik JY; Gemmill TR; Sharfstein ST; Linhardt RJ
J Biol Chem; 2013 Dec; 288(52):37308-18. PubMed ID: 24247246
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
5. Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells.
Baik JY; Wang CL; Yang B; Linhardt RJ; Sharfstein S
Bioengineered; 2012; 3(4):227-31. PubMed ID: 22714556
[TBL] [Abstract][Full Text] [Related]
6. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
[TBL] [Abstract][Full Text] [Related]
7. Metabolic engineering of CHO cells to alter lactate metabolism during fed-batch cultures.
Toussaint C; Henry O; Durocher Y
J Biotechnol; 2016 Jan; 217():122-31. PubMed ID: 26603123
[TBL] [Abstract][Full Text] [Related]
8. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
[TBL] [Abstract][Full Text] [Related]
9. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
[TBL] [Abstract][Full Text] [Related]
10. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
[TBL] [Abstract][Full Text] [Related]
11. High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin.
Zhang J; Suflita M; Fiaschetti CM; Li G; Li L; Zhang F; Dordick JS; Linhardt RJ
J Appl Microbiol; 2015 Jan; 118(1):92-8. PubMed ID: 25362996
[TBL] [Abstract][Full Text] [Related]
12. Quantitative feature extraction from the Chinese hamster ovary bioprocess bibliome using a novel meta-analysis workflow.
Golabgir A; Gutierrez JM; Hefzi H; Li S; Palsson BO; Herwig C; Lewis NE
Biotechnol Adv; 2016; 34(5):621-633. PubMed ID: 26948029
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
[TBL] [Abstract][Full Text] [Related]
14. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
15. Model-based optimization of temperature and pH shift to increase volumetric productivity of a Chinese hamster ovary fed-batch process.
Paul K; Rajamanickam V; Herwig C
J Biosci Bioeng; 2019 Dec; 128(6):710-715. PubMed ID: 31277910
[TBL] [Abstract][Full Text] [Related]
16. Metabolic engineering of Chinese hamster ovary cells towards reduced biosynthesis and accumulation of novel growth inhibitors in fed-batch cultures.
Mulukutla BC; Mitchell J; Geoffroy P; Harrington C; Krishnan M; Kalomeris T; Morris C; Zhang L; Pegman P; Hiller GW
Metab Eng; 2019 Jul; 54():54-68. PubMed ID: 30851381
[TBL] [Abstract][Full Text] [Related]
17. Blockage of undesirable endocytosis of recombinant human growth/differentiation factor-5 in Chinese hamster ovary cell cultures requires heparin analogs with specific chain lengths.
Kim MG; Lee GM
Biotechnol J; 2021 Oct; 16(10):e2100227. PubMed ID: 34347378
[TBL] [Abstract][Full Text] [Related]
18. Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies.
Deng JQ; Li Y; Wang YJ; Cao YL; Xin SY; Li XY; Xi RM; Wang FS; Sheng JZ
Nat Commun; 2024 May; 15(1):3755. PubMed ID: 38704385
[TBL] [Abstract][Full Text] [Related]
19. Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.
Ventini DC; Damiani R; Sousa AP; de Oliveira JE; Peroni CN; Ribela MT; Bartolini P; Tonso A; Soares CR; Pereira CA
Appl Biochem Biotechnol; 2011 Jun; 164(4):401-9. PubMed ID: 21181451
[TBL] [Abstract][Full Text] [Related]
20. Metabolic analysis of antibody producing CHO cells in fed-batch production.
Dean J; Reddy P
Biotechnol Bioeng; 2013 Jun; 110(6):1735-47. PubMed ID: 23296898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
